Table 1.
Maternal characteristics of the study cohort of 84 women with GDM
| Maternal characteristic | Whole group (N = 84) | Male infant (n = 42) | Female infant (n = 42) |
|---|---|---|---|
| Gestation at delivery (weeks) | 39.3 ± 1.1 | 39.3 ± 1.0 | 39.4 ± 1.2 |
| Maternal age (years) | 32.5 ± 4.8 | 32.8 ± 5.0 | 32.3 ± 4.6 |
| Maternal BMI (kg/m2) | 28.2 ± 7.7 | 28.1 ± 6.4 | 28.3 ± 8.8 |
| Number of women overweight (BMI 25–30) | 22 (26.2) | 13 (31.0) | 9 (21.4) |
| Number of women obese (BMI >30) | 28 (33.3) | 15 (35.7) | 13 (31.0) |
| Nulliparous | 42 (50) | 23 (55) | 19 (45) |
| Gestational weight gain (kg) | 12.0 ± 6.1 | 11.8 ± 5.7 | 12.3 ± 6.8 |
| Ethnicity | |||
| White | 57 (67.9) | 30 (71.4) | 27 (64.3) |
| Indian | 8 (9.5) | 4 (9.5) | 4 (9.5) |
| Other* | 12 (14.3) | 5 (11.9) | 7 (16.7) |
| Unrecorded | 7 (8.3) | 3 (7.1) | 4 (9.5) |
| Smokers | 5 (5.9) | 3 (7.1) | 2 (4.8) |
| Insulin therapy | 20 (24) | 11 (26) | 9 (21) |
| Metformin therapy | 6 (7.1) | 5 (11.9) | 1 (2.4) |
| GTT fasting (mmol/L) | 4.88 ± 0.65 | 4.95 ± 0.72 | 4.80 ± 0.55 |
| GTT 2 h (mmol/L) | 9.01 ± 1.08 | 9.06 ± 0.85 | 8.95 ± 1.28 |
| Gestation at diagnosis (weeks) | 27.8 ± 4.9 | 27.7 ± 5.4 | 27.9 ± 4.3 |
| Treatment commenced (weeks) | 29.2 ± 4.8 | 29.2 ± 5.3 | 29.2 ± 4.4 |
| Mean fasting BGL (mmol/L) | 4.96 ± 0.47 | 5.01 ± 0.46 | 4.90 ± 0.49 |
| Mean postprandial BGL (mmol/L) | 6.06 ± 0.52 | 6.06 ± 0.49 | 6.06 ± 0.55 |
Data are mean ± SD or n (%). GTT, glucose tolerance test.
*Other ethnicities (n) include Aboriginal (3), Filipino (2), Maori (2), Malaysian (1), Solomon Islander (1), Vietnamese (1), Chinese (1), and Afghani (1).